Aakaar Medical Technologies Ltd Announces Groundbreaking SME IPO on NSE Emerge

Aakaar Medical Technologies Ltd, a leader in cosmetic dermatology, plans to launch its SME IPO on NSE Emerge on 20th June 2025, to raise ₹27 Crores. Utilizing B2B channels for distribution, the company focuses on aesthetic products and plans to use funds for working capital and other corporate purposes.

Aakaar Medical Technologies Ltd, based in Mumbai, is set to launch its SME Initial Public Offering (IPO) on NSE Emerge, marking a significant milestone in the cosmetic dermatology industry. The IPO is scheduled to open on June 20, 2025, with a target capital raise of ₹27 Crores (upper band).

Under the leadership of Founder & MD Mr. Dilip Meswani and CEO Dr. Rahul Sawakhande, Aakaar offers a diverse range of 150+ SKUs. The company has exclusive international partnerships and operates through B2B channels, primarily serving dermatologists, plastic surgeons, and aesthetic physicians.

The IPO includes 37,50,400 equity shares with a face value of ₹10 each. The financial proceeds are earmarked mainly for working capital needs. This move underscores Aakaar's commitment to expansion and innovation in the medical cosmetics sector, as detailed by their robust financial performance in recent years.

(With inputs from agencies.)